NCT06717802 Endometrial Receptivity Prediction During in Vitro Fertilization Using Artificial Intelligence
| NCT ID | NCT06717802 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Gottsegen National Cardiovascular Institute |
| Condition | Infertility |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,500 participants in total. It began in 2025-06-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators plan to use artificial intelligence to analyse vaginal ultrasound images of the uterine lining (endometrium) taken during routine IVF treatment, which may predict implantation success during IVF treatment. Participation in the study is voluntary, involves no additional testing or intervention beyond routine procedures, and consent can be withdrawn verbally or in writing at any time without cause or adverse consequences. Over a three-year period, the trial is expected to enrol approximately 1,500 patients between the ages of 18 and 40 who are indicated for IVF treatment and who volunteer for treatment. Patients enrolled in the study will not be required to attend more clinic visits during treatment than they would otherwise have to. During the trial, certain patient-specific data (age, indication for treatment, body mass index), stimulation-specific data (duration of stimulation, type and dose of drug, endometrial thickness), ultrasound scans and outcome-specific data (treatment failure, biochemical pregnancy, clinical pregnancy) will be collected. The data will be stored in a secure database. The data collected during the study will only be accessible to the professionals involved in the study and no information, including personal data, will be disclosed to third parties.
Eligibility Criteria
Inclusion Criteria: * Female patient 18-40 years, for whom IVF is indicated * Maximum 3 unsuccessful previous embryo transfers * Only cycles in which single blastocyst is transferred Exclusion Criteria: * Congenital uterine anomalies, fibroids, adenomyosis, Asherman-syndrome or any other conditions resulting in malformation of the uterus * Presence of hydrosalpinx * Endometriosis * Planned freeze-all cycle * Positive hepatitis B, hepatitis C or HIV screening test
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06717802 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 40 Years, studying Infertility. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06717802 currently recruiting?
Yes, NCT06717802 is actively recruiting participants. Contact the research team at marton.kolossvary@gokvi.hu for enrollment information.
Where is the NCT06717802 trial being conducted?
This trial is being conducted at Budapest, Hungary.
Who is sponsoring the NCT06717802 clinical trial?
NCT06717802 is sponsored by Gottsegen National Cardiovascular Institute. The trial plans to enroll 1,500 participants.